Signal active
Bio
Nicole Vitullo joined Domain Associates, L.L.C. in 1999 and became a Partner in 2004. She has full management responsibility for Domain Public Equity Partners, L.P. and is also involved in distribution/liquidation strategies for the public companies in Domain Associate’s venture capital portfolios.
Present board memberships include Celator Pharmaceuticals, Inc.; Cerexa, Inc.; Ruxton Pharmaceuticals; and Marinus Pharmaceuticals.
Past Board memberships include Onyx Pharmaceuticals and Eunoe, Inc. From 1992-1999, Ms. Vitullo was Senior Vice President at Rothschild Asset Management, Inc. where she had responsibility for the U.S. public market investments of International Biotechnology Trust plc and Biotechnology Investments Limited.
From 1991-1992, Ms. Vitullo served as the Director of Corporation Communications and Investor Relations at Cephalon, a publicly traded biotechnology company.
Prior to Cephalon, Ms. Vitullo spent 12 years at Eastman Kodak, most recently in Corporation Development where she was involved in the development management of Kodak’s venture capital activities.
Ms. Vitullo has a B.A. and an M.B.A. from the University of Rochester.
Location
New York, New York, United States, North America
Social
Primary Organization
1985
306
63
93
11-50
Venture Capital, Biotechnology, Health Care
Jobs history
2
Allay Therapeutics
Board Member
2023 - Current
Achillion Pharmaceuticals
Board Chair
2019 - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Nicole Vitullo is the Partner at Domain Associates, based in New York, New York, United States, North America. With a background in Venture Capital, Nicole Vitullo has a rich history of leadership and innovation. Nicole Vitullo studied MBA Finance, General @ University of Rochester. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Recommendation from your interest
N/A
Investment portfolio
1
0
Personal investment
0
There is no personal investment available on this profile
Partner investment
9
Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
---|---|---|---|---|
Sep 23, 2014 | VentiRx Pharmaceuticals | Series B - VentiRx Pharmaceuticals | Domain Associates | 50.6M |
Nov 27, 2018 | Antios Therapeutics | Series A - Antios Therapeutics | Domain Associates | 25.0M |
Apr 12, 2021 | Antios Therapeutics | Series B - Antios Therapeutics | Domain Associates | 96.0M |
Nov 03, 2021 | Antios Therapeutics | Series B - Antios Therapeutics | Domain Associates | 75.0M |
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.